Back to search
FDAFDA · Food and drugs·Recall number D-0012-2018

methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10

Published October 25, 2017 · Recall initiated: September 25, 2017

Summary

FDA records drug Class II recall D-0012-2018, published October 25, 2017 and initiated September 25, 2017. Recalling firm: RXQ Compounding LLC; Status: Terminated; Reported quantity: 945 vials; Lot: Lot: 04252017@1, exp 5/9/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RXQ Compounding LLC
Distributor
TX, LA, PA, MA, FL, and OH
Lot
Lot: 04252017@1, exp 5/9/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10 recalled?

Yes. FDA published recall D-0012-2018 on October 25, 2017. Reported hazard: Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone